Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IQVIA HOLDINGS INC.

(IQV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IQVIA : Earnings Flash (IQV) IQVIA HOLDINGS Posts Q2 EPS $2.13, vs. Street Est of $2.08

07/27/2021 | 07:06am EDT


ę MT Newswires 2021
All news about IQVIA HOLDINGS INC.
09/17ANI PHARMACEUTICALS : Launches Generic Hypertension Drug
MT
09/13NRX PHARMACEUTICALS : IQVIA to Provide Pharmacovigilance Services for NRx's COVI..
MT
09/13IQVIA : and NRx Pharmaceuticals Collaborate on Potential Medical Support for Nov..
BU
09/10IQVIA : Argus Research Adjusts IQVIA Holdings' Price Target to $290 from $260, K..
MT
09/08IQVIA : Collaborates with HealthCore to Advance Clinical Research Using Real-Wor..
BU
09/08IQVIA Announces Strategic Collaboration with HealthCore, Inc
CI
09/08PRESS RELEASE : Novartis: Sandoz strengthens pipeline by entering into agreement..
DJ
09/02IQVIA : CFO, Ron Bruehlman, to Speak at the Baird 2021 Global Healthcare Confere..
BU
09/01IQVIA : Launches New A.I.-Powered MI Contact Center For Life Sciences
BU
09/01IQVIA Launches New A.I.-Powered MI Contact Center for Life Sciences
CI
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2021 13 665 M - -
Net income 2021 806 M - -
Net Debt 2021 10 224 M - -
P/E ratio 2021 61,8x
Yield 2021 -
Capitalization 49 116 M 49 116 M -
EV / Sales 2021 4,34x
EV / Sales 2022 3,95x
Nbr of Employees 74 000
Free-Float 74,2%
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 256,33 $
Average target price 275,67 $
Spread / Average Target 7,54%
EPS Revisions
Managers and Directors
Ari Bousbib Chairman, President & Chief Executive Officer
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
W. Richard Staub President-Research & Development Solutions
Kevin C. Knightly President-Technology & Commercial Solutions
Sector and Competitors
1st jan.Capi. (M$)
IQVIA HOLDINGS INC.43.07%49 116
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420
ALNYLAM PHARMACEUTICALS, INC.46.45%22 621